Xponance, Inc. Karuna Therapeutics, Inc. Transaction History

Xponance, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 31, 2024	SELL	$161.01 - $317.85 $34,939 - $68,973	-217 Reduced 4.67%	4,432 $1.4 Million
Q3 2023 Oct 23, 2023	BUY	$164.66 - $218.08 $4,775 - $6,324	29 Added 0.63%	4,649 $786,000
Q2 2023 Jul 13, 2023	BUY	$176.32 - $240.22 $488,582 - $665,649	2,771 Added 149.86%	4,620 $1 Million
Q1 2023 Apr 17, 2023	BUY	$161.33 - $204.36 $19,520 - $24,727	121 Added 7.0%	1,849 $335,000
Q4 2022 Jan 23, 2023	BUY	$191.53 - $236.82 $10,342 - $12,788	54 Added 3.23%	1,728 $0
Q3 2022 Oct 24, 2022	BUY	$123.79 - $277.42 $207,224 - $464,401	1,674 New	1,674 $377,000

332K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of Xponance, Inc., based on Form 13F filings with the SEC.

Stay updated on Xponance, Inc. with notifications on news.